Xtant Medical Holdings 주식 주식분석 | 주식가격 | 뉴스 | XTNT | US98420P3082 | A2JDJS

날짜	Xtant Medical Holdings 주식 가격
	0.58 undefined
	0.57 undefined
	0.59 undefined
	0.60 undefined
	0.60 undefined
	0.59 undefined
	0.60 undefined
	0.65 undefined
	0.65 undefined
	0.63 undefined
	0.63 undefined
	0.65 undefined
	0.65 undefined
	0.68 undefined
	0.67 undefined
	0.67 undefined
	0.68 undefined
	0.68 undefined
	0.74 undefined
	0.70 undefined
	0.57 undefined

날짜	Xtant Medical Holdings 매출	Xtant Medical Holdings EBIT	Xtant Medical Holdings 이익
2026e	167.89 백만 undefined	6.73 백만 undefined	4.24 백만 undefined
2025e	143.41 백만 undefined	-2.04 백만 undefined	-1.41 백만 undefined
2024e	121.18 백만 undefined	-9.69 백만 undefined	-12.03 백만 undefined
2023	91.3 백만 undefined	-10.16 백만 undefined	660,000 undefined
2022	57.97 백만 undefined	-6.76 백만 undefined	-8.49 백만 undefined
2021	55.26 백만 undefined	-3.85 백만 undefined	-4.85 백만 undefined
2020	53.34 백만 undefined	-751,000 undefined	-7.02 백만 undefined
2019	64.68 백만 undefined	-2.25 백만 undefined	-8.22 백만 undefined
2018	72.2 백만 undefined	-7.39 백만 undefined	-70.1 백만 undefined
2017	82.61 백만 undefined	-13.67 백만 undefined	-52.41 백만 undefined
2016	90 백만 undefined	-6.14 백만 undefined	-19.49 백만 undefined
2015	59.35 백만 undefined	-9.25 백만 undefined	-2.17 백만 undefined
2014	35.33 백만 undefined	-5.35 백만 undefined	-10.51 백만 undefined
2013	33.07 백만 undefined	-8.28 백만 undefined	-12.69 백만 undefined
2012	32.98 백만 undefined	-4.94 백만 undefined	-7.71 백만 undefined
2011	30.15 백만 undefined	-6.45 백만 undefined	-3.01 백만 undefined
2010	15.42 백만 undefined	-8.61 백만 undefined	-19.47 백만 undefined
2009	300,000 undefined	10,000 undefined	10,000 undefined
2008	460,000 undefined	-20,000 undefined	-20,000 undefined
2007	200,000 undefined	10,000 undefined	10,000 undefined

	매출	EBIT	이익
2007	200,000 USD	10,000 USD	10,000 USD
2008	460,000 USD	-20,000 USD	-20,000 USD
2009	300,000 USD	10,000 USD	10,000 USD
2010	15.42 백만 USD	-8.61 백만 USD	-19.47 백만 USD
2011	30.15 백만 USD	-6.45 백만 USD	-3.01 백만 USD
2012	32.98 백만 USD	-4.94 백만 USD	-7.71 백만 USD
2013	33.07 백만 USD	-8.28 백만 USD	-12.69 백만 USD
2014	35.33 백만 USD	-5.35 백만 USD	-10.51 백만 USD
2015	59.35 백만 USD	-9.25 백만 USD	-2.17 백만 USD
2016	90 백만 USD	-6.14 백만 USD	-19.49 백만 USD
2017	82.61 백만 USD	-13.67 백만 USD	-52.41 백만 USD
2018	72.2 백만 USD	-7.39 백만 USD	-70.1 백만 USD
2019	64.68 백만 USD	-2.25 백만 USD	-8.22 백만 USD
2020	53.34 백만 USD	-751,000 USD	-7.02 백만 USD
2021	55.26 백만 USD	-3.85 백만 USD	-4.85 백만 USD
2022	57.97 백만 USD	-6.76 백만 USD	-8.49 백만 USD
2023	91.3 백만 USD	-10.16 백만 USD	660,000 USD
2024e	121.18 백만 USD	-9.69 백만 USD	-12.03 백만 USD
2025e	143.41 백만 USD	-2.04 백만 USD	-1.41 백만 USD
2026e	167.89 백만 USD	6.73 백만 USD	4.24 백만 USD

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0	0	0	15	30	32	33	35	59	90	82	72	64	53	55	57	91	121	143	167
-	-	-	-	100.00	6.67	3.13	6.06	68.57	52.54	-8.89	-12.20	-11.11	-17.19	3.77	3.64	59.65	32.97	18.18	16.78
-	-	-	80.00	70.00	68.75	54.55	62.86	66.10	68.89	60.98	59.72	65.63	64.15	58.18	56.14	60.44	-	-	-
0	0	0	12	21	22	18	22	39	62	50	43	42	34	32	32	55	0	0	0
0	0	0	-8	-6	-4	-8	-5	-9	-6	-13	-7	-2	0	-3	-6	-10	-9	-2	6
-	-	-	-53.33	-20.00	-12.50	-24.24	-14.29	-15.25	-6.67	-15.85	-9.72	-3.13	-	-5.45	-10.53	-10.99	-7.44	-1.40	3.59
0	0	0	-19	-3	-7	-12	-10	-2	-19	-52	-70	-8	-7	-4	-8	0	-12	-1	4
-	-	-	-	-84.21	133.33	71.43	-16.67	-80.00	850.00	173.68	34.62	-88.57	-12.50	-42.86	100.00	-	-	-91.67	-500.00
0.04	0.04	0.04	0.27	0.32	0.35	0.4	0.5	0.75	1.06	1.51	11.74	13.16	28.5	85.46	94.09	126.79	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0	0	0.1	0.3	0.8	4.9	3	4.47	6.37	2.58	2.86	6.8	5.24	2.34	18.24	20.3	5.72
0	0.1	1.6	4.1	7.1	7.2	4.8	4.43	15.39	18.99	12.71	9.99	10.12	6.88	7.15	10.85	20.73
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	5	5.4	8.5	13.1	10.8	9.56	22.68	26.27	22.42	17.3	16.1	21.41	17.95	17.29	36.89
0	0	0	0.6	0.3	0.4	0.6	0.65	0.6	1.15	1.71	0.59	0.78	0.74	0.99	0.88	1.54
0	0.1	6.7	10.4	16.7	25.6	19.2	19.11	45.04	48.99	39.7	34.68	32.25	31.37	44.33	49.32	64.87
0	0	3.2	3.4	3.8	5.2	5.2	4.65	11.82	15.84	9.91	7.17	6.8	6.04	6.47	7.17	10.22
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	100	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0.6	0.4	0.7	0.6	0.6	0.66	40.24	35.94	13.83	0.57	0.52	0.46	0.4	0.34	10.09
0	0	0	0	0.7	0.7	0	0	41.53	41.53	41.54	3.21	3.21	3.21	3.21	3.21	7.3
0	0	0	1.5	1.4	2.4	3.9	3.53	2.4	1.8	0.73	0.79	0.39	0.4	0.29	0.2	0.14
0	0	3.8	5.4	6.6	8.9	9.7	8.84	95.99	95.12	66.01	11.75	10.91	10.1	10.36	10.91	27.74
0	0.1	10.5	15.8	23.3	34.5	28.9	27.95	141.03	144.1	105.71	46.42	43.16	41.47	54.69	60.23	92.61

0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	22.2	36.3	45.5	51.9	56.5	63.09	81.92	85.46	86.25	171.27	179.06	244.85	266.07	277.84	294.33
0	0	-17.6	-36.9	-40	-47.7	-60.4	-70.87	-73.04	-92.53	-144.95	-215.05	-223.27	-230.34	-235.19	-243.67	-243.01
0	0	0	0	0	0	0	0	0	0	0	0	-0.01	-0.08	-0.09	-0.11	28.87
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	4.6	-0.6	5.5	4.2	-3.9	-7.77	8.88	-7.07	-58.7	-43.77	-44.2	14.51	30.88	34.17	51.35
0	0.1	1.4	2.8	3.2	4.4	3.4	4.13	10.79	11.11	9.48	6.47	2.19	2.29	2.62	3.49	7.05
0	0	0.5	1.4	3.8	2.4	3.6	1.92	9.6	8.98	15.85	5.15	7.02	6.54	4.81	5.95	11.25
0	0	0.1	9.7	2.3	1	1.6	1.32	1.05	0.33	0.13	0.01	0.01	0	0	0	0
0	0	2.1	0	0	0	0	0	0	10.45	0	0	0	0	0	0	0
0	0	1.3	0.3	1.7	0.9	1.1	1.11	0.04	0.24	0.37	0.43	0.18	16.82	3.65	5.77	4.69
0	0.1	5.4	14.2	11	8.7	9.7	8.48	21.47	31.12	25.82	12.05	9.39	25.65	11.08	15.22	22.99
0	0	0.4	2.2	6.7	14.7	16.5	20.88	110.68	120.05	138.59	78.14	76.24	0	11.89	9.87	17.28
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21
0	0	0	0	0	6.8	6.6	0	0	0	0	0	1.73	1.3	0.84	0.97	0.97
0	0	0.4	2.2	6.7	21.5	23.1	20.88	110.68	120.05	138.59	78.14	77.97	1.3	12.73	10.84	18.27
0	0.1	5.8	16.4	17.7	30.2	32.8	29.36	132.15	151.17	164.4	90.19	87.36	26.95	23.81	26.06	41.26
0	0.1	10.4	15.8	23.2	34.4	28.9	21.59	141.03	144.1	105.71	46.42	43.16	41.47	54.69	60.23	92.61

2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	0	-19	-3	-7	-12	-10	-2	-19	-52	-70	-8	-7	-4	-8	0
0	0	0	0	0	0	0	4	7	8	6	3	2	1	1	3
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1
0	0	-3	-5	-6	2	0	1	-8	3	0	-2	-3	0	-2	-3
0	0	16	2	3	4	4	-12	7	40	64	7	8	5	7	-7
0	0	0	1	1	0	3	2	5	0	0	0	0	0	1	2
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-8,000	-7,000	-10,000	-5,000	-7,000	-9,000	-14,000	0	1,000	0	0	0	-5,000	-9,000
0	0	0	-1	-1	0	0	-75	-5	-1	0	0	-1	-2	-1	-1
0	0	0	-1	-1	0	0	-73	-5	-1	0	0	-1	-1	-1	-24
0	0	0	0	0	0	0	1,000	0	0	0	0	0	0	0	-23,000
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	3	4	12	0	3	82	13	2	0	0	0	0	0	5
0	0	5	4	3	4	5	2	3	0	0	0	0	18	9	14
0	0	9	8	16	3	9	84	16	2	3	0	0	17	9	19
0	0	0	0	0	0	0	0	0	0	3	0	-1	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	4	-1	1	1	-3	0	3	-1	-2	16	2	-14
0.04	-0.08	-9.19	-8.46	-12.63	-6.31	-7.62	-84.34	-20.24	-2.18	0.59	-1.29	-2.28	-1.68	-7.11	-10.97
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Xtant Medical Holdings 브루토마진	Xtant Medical Holdings 이익 마진	Xtant Medical Holdings EBIT-마진	Xtant Medical Holdings 이익 마진
2026e	60.75 %	4.01 %	2.53 %
2025e	60.75 %	-1.42 %	-0.99 %
2024e	60.75 %	-8 %	-9.92 %
2023	60.75 %	-11.13 %	0.72 %
2022	55.44 %	-11.65 %	-14.64 %
2021	58.79 %	-6.97 %	-8.77 %
2020	64.48 %	-1.41 %	-13.17 %
2019	65.73 %	-3.48 %	-12.71 %
2018	60.23 %	-10.24 %	-97.09 %
2017	60.65 %	-16.54 %	-63.44 %
2016	69.21 %	-6.83 %	-21.66 %
2015	65.86 %	-15.59 %	-3.66 %
2014	63.11 %	-15.15 %	-29.74 %
2013	57.12 %	-25.04 %	-38.37 %
2012	68.65 %	-14.98 %	-23.38 %
2011	69.78 %	-21.39 %	-9.98 %
2010	78.15 %	-55.84 %	-126.26 %
2009	26.67 %	3.33 %	3.33 %
2008	15.22 %	-4.35 %	-4.35 %
2007	35 %	5 %	5 %

	브루토마진	EBIT-마진	이익 마진
2007	35 %	5 %	5 %
2008	15.22 %	-4.35 %	-4.35 %
2009	26.67 %	3.33 %	3.33 %
2010	78.15 %	-55.84 %	-126.26 %
2011	69.78 %	-21.39 %	-9.98 %
2012	68.65 %	-14.98 %	-23.38 %
2013	57.12 %	-25.04 %	-38.37 %
2014	63.11 %	-15.15 %	-29.74 %
2015	65.86 %	-15.59 %	-3.66 %
2016	69.21 %	-6.83 %	-21.66 %
2017	60.65 %	-16.54 %	-63.44 %
2018	60.23 %	-10.24 %	-97.09 %
2019	65.73 %	-3.48 %	-12.71 %
2020	64.48 %	-1.41 %	-13.17 %
2021	58.79 %	-6.97 %	-8.77 %
2022	55.44 %	-11.65 %	-14.64 %
2023	60.75 %	-11.13 %	0.72 %
2024e	60.75 %	-8 %	-9.92 %
2025e	60.75 %	-1.42 %	-0.99 %
2026e	60.75 %	4.01 %	2.53 %

날짜	Xtant Medical Holdings 주당 매출	Xtant Medical Holdings EBIT 당 주식	Xtant Medical Holdings 주당 이익
2026e	1.21 undefined	0 undefined	0.03 undefined
2025e	1.03 undefined	0 undefined	-0.01 undefined
2024e	0.87 undefined	0 undefined	-0.09 undefined
2023	0.72 undefined	-0.08 undefined	0.01 undefined
2022	0.62 undefined	-0.07 undefined	-0.09 undefined
2021	0.65 undefined	-0.05 undefined	-0.06 undefined
2020	1.87 undefined	-0.03 undefined	-0.25 undefined
2019	4.91 undefined	-0.17 undefined	-0.62 undefined
2018	6.15 undefined	-0.63 undefined	-5.97 undefined
2017	54.79 undefined	-9.06 undefined	-34.76 undefined
2016	85.24 undefined	-5.82 undefined	-18.46 undefined
2015	78.65 undefined	-12.26 undefined	-2.88 undefined
2014	71.21 undefined	-10.79 undefined	-21.18 undefined
2013	82.67 undefined	-20.7 undefined	-31.72 undefined
2012	94.23 undefined	-14.11 undefined	-22.03 undefined
2011	94.22 undefined	-20.16 undefined	-9.41 undefined
2010	57.11 undefined	-31.89 undefined	-72.11 undefined
2009	7.5 undefined	0.25 undefined	0.25 undefined
2008	11.5 undefined	-0.5 undefined	-0.5 undefined
2007	5 undefined	0.25 undefined	0.25 undefined

	주당 매출	EBIT 당 주식	주당 이익
2007	5 USD	0.25 USD	0.25 USD
2008	11.5 USD	-0.5 USD	-0.5 USD
2009	7.5 USD	0.25 USD	0.25 USD
2010	57.11 USD	-31.89 USD	-72.11 USD
2011	94.22 USD	-20.16 USD	-9.41 USD
2012	94.23 USD	-14.11 USD	-22.03 USD
2013	82.67 USD	-20.7 USD	-31.72 USD
2014	71.21 USD	-10.79 USD	-21.18 USD
2015	78.65 USD	-12.26 USD	-2.88 USD
2016	85.24 USD	-5.82 USD	-18.46 USD
2017	54.79 USD	-9.06 USD	-34.76 USD
2018	6.15 USD	-0.63 USD	-5.97 USD
2019	4.91 USD	-0.17 USD	-0.62 USD
2020	1.87 USD	-0.03 USD	-0.25 USD
2021	0.65 USD	-0.05 USD	-0.06 USD
2022	0.62 USD	-0.07 USD	-0.09 USD
2023	0.72 USD	-0.08 USD	0.01 USD
2024e	0.87 USD	0 USD	-0.09 USD
2025e	1.03 USD	0 USD	-0.01 USD
2026e	1.21 USD	0 USD	0.03 USD

Segmente	2023	2022	2021	2020	2019
Orthobiologics	58.61 백만 USD	47.14 백만 USD	42.26 백만 USD	39.31 백만 USD	46.66 백만 USD
Spinal Implant	32.7 백만 USD	10.82 백만 USD	12.89 백만 USD	13.88 백만 USD	17.87 백만 USD
Other Revenue	-	11,000 USD	117,000 USD	149,000 USD	147,000 USD

	Orthobiologics	Spinal Implant	Other Revenue
2019	46.66 백만 USD	17.87 백만 USD	147,000 USD
2020	39.31 백만 USD	13.88 백만 USD	149,000 USD
2021	42.26 백만 USD	12.89 백만 USD	117,000 USD
2022	47.14 백만 USD	10.82 백만 USD	11,000 USD
2023	58.61 백만 USD	32.7 백만 USD	0 USD

날짜	Rest of World	United States
2023	5.44 백만 USD	85.86 백만 USD
2022	807,000 USD	57.16 백만 USD
2021	693,000 USD	54.57 백만 USD

	Rest of World	United States
2021	693,000 USD	54.57 백만 USD
2022	807,000 USD	57.16 백만 USD
2023	5.44 백만 USD	85.86 백만 USD

	주식 수량
2007	40,000 Aktien
2008	40,000 Aktien
2009	40,000 Aktien
2010	270,000 Aktien
2011	320,000 Aktien
2012	350,000 Aktien
2013	400,000 Aktien
2014	496,160 Aktien
2015	754,590 Aktien
2016	1.06 백만 Aktien
2017	1.51 백만 Aktien
2018	11.74 백만 Aktien
2019	13.16 백만 Aktien
2020	28.5 백만 Aktien
2021	85.46 백만 Aktien
2022	94.09 백만 Aktien
2023	126.79 백만 Aktien
2024e	126.79 백만 Aktien
2025e	126.79 백만 Aktien
2026e	126.79 백만 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.02	-0.03 (-47.06 %)	2024 Q2
-0.02	-0.03 (-96.08 %)	2024 Q1
-0.03	-0.03 (-17.65 %)	2023 Q4
-0.02	0.07 (443.14 %)	2023 Q3
-0.02	-0.02 (1.96 %)	2023 Q2
-0.03	-0.02 (34.64 %)	2023 Q1
0	-0.02 (0 %)	2022 Q4
-0.11	-0.1 (10.87 %)	2020 Q3
-0.11	-0.19 (-69.34 %)	2020 Q2
-0.21	-0.12 (43.98 %)	2019 Q4
-0.29	-0.14 (50.98 %)	2019 Q3
-0.37	-0.21 (42.81 %)	2019 Q1
-0.33	-0.23 (29.53 %)	2018 Q4
-0.18	-0.21 (-17.65 %)	2018 Q3
-0.27	-0.38 (-43.29 %)	2018 Q2
-3.56	-7.15 (-100.85 %)	2017 Q4
-3.18	-5.64 (-77.22 %)	2017 Q3
-2.69	-5.4 (-100.53 %)	2017 Q2
-3.61	-3.48 (3.62 %)	2017 Q1
-3.71	-3.72 (-0.19 %)	2016 Q4
-4.59	-4.8 (-4.58 %)	2016 Q3
-4.53	-3.96 (12.56 %)	2016 Q2
-5.02	-5.28 (-5.21 %)	2016 Q1
-2.69	-4.92 (-82.71 %)	2015 Q4
-2.26	-5.64 (-149.07 %)	2015 Q3
-4.22	-4.8 (-13.67 %)	2015 Q2
-4.35	-5.64 (-29.8 %)	2015 Q1
-4.28	-5.52 (-28.85 %)	2014 Q4
-2.82	-2.28 (19.01 %)	2014 Q3
-5.69	-4.2 (26.21 %)	2014 Q2
-4.9	-9.6 (-96.08 %)	2014 Q1
-8.98	-8.4 (6.42 %)	2013 Q4
-5.81	-9.6 (-65.12 %)	2013 Q3
-4.49	-4.8 (-6.95 %)	2013 Q2
-5.71	-4.8 (15.97 %)	2013 Q1
-4.16	-13.2 (-217.19 %)	2012 Q4
-4.65	-7.2 (-54.8 %)	2012 Q3
-5.39	2.4 (144.56 %)	2012 Q2
-5.3	-3.6 (32.13 %)	2012 Q1
-4.16	-13.2 (-217.19 %)	2011 Q4
-1.22	-9.6 (-684.31 %)	2011 Q3
-7.34	-1.2 (83.66 %)	2011 Q2

%-지분	이름	주식	변경
52.71040 %	OrbiMed Advisors, LLC	73,114,592	0
5.78732 %	Altium Capital Management LP	8,027,593	-906,769
4.32222 %	Vizirgianakis (Stavros G)	5,995,355	-2,355
2.88371 %	Nantahala Capital Management, LLC	4,000,000	0
1.22540 %	Browne (Sean E.)	1,699,750	731,632
1.08139 %	The Vanguard Group, Inc.	1,499,993	14,653
0.76946 %	Beeson (Jonn R.)	1,067,321	-93,131
0.53414 %	Renaissance Technologies LLC	740,910	71,172
0.42825 %	AMH Equity, Ltd.	594,029	0
0.33788 %	AWM Investment Company, Inc.	468,680	0
0.33679 %	Brandt (Kevin D)	467,159	184,209
0.32337 %	Bakewell (John K)	448,546	70,235
0.32212 %	McNamara (Robert E)	446,809	70,235
0.26566 %	Bridgeway Capital Management, LLC	368,500	200,000
0.21682 %	Eggenberg (Michael)	300,752	215,415
0.21682 %	Rizzo (Matthew S.)	300,752	215,415
0.20705 %	Neils (Scott C)	287,196	177,551
0.18881 %	Geode Capital Management, L.L.C.	261,905	1,401
0.15285 %	Crescent Grove Advisors, LLC	212,024	0
0.14404 %	Schallenberger (Mark A.)	199,801	177,551
0.13767 %	Mitchell-Keller (Lori)	190,962	145,180
0.11488 %	Millennium Management LLC	159,350	159,350
0.09746 %	BlackRock Institutional Trust Company, N.A.	135,181	14,712
0.06655 %	Susquehanna International Group, LLP	92,305	79,578
0.04610 %	BlackRock (Netherlands) B.V.	63,946	63,946
0.04503 %	Citi Investment Research (US)	62,455	56,363
0.04316 %	Citadel Advisors LLC	59,866	28,105
0.04229 %	Northern Trust Investments, Inc.	58,666	16,257
0.03126 %	ExodusPoint Capital Management, LP	43,361	43,361
0.02577 %	Midwest Professional Planners, Ltd	35,744	0
0.02433 %	BlackRock Advisors (UK) Limited	33,744	33,744
0.02392 %	Goldman Sachs & Company, Inc.	33,176	20,253
0.02369 %	State Street Global Advisors (US)	32,866	0
0.02091 %	PGIM Quantitative Solutions LLC	29,000	10,200
0.02021 %	BofA Global Research (US)	28,030	28,030
0.00998 %	BlackRock Investment Management (UK) Ltd.	13,850	13,850
0.00746 %	Tower Research Capital LLC	10,348	-3,745
0.00721 %	Private Advisor Group LLC	10,000	10,000
0.00647 %	BlackRock Investment Management, LLC	8,977	8,977
0.00092 %	Qube Research & Technologies Ltd	1,278	1,278
0.00082 %	Fidelity Management & Research Company LLC	1,132	1,048
0.00027 %	Wells Fargo Bank, N.A.	369	21
0.00021 %	American Portfolios Advisors, Inc	291	0
0.00021 %	Osaic Holdings, Inc.	291	-500
0.00007 %	UBS Financial Services, Inc.	92	-4,127
0.00006 %	J.P. Morgan Securities LLC	87	55
0.00001 %	Cornerstone Planning Group LLC	12	0
0.00000 %	Wells Fargo Advisors	1	0
0 %	OneDigital Investment Advisors LLC	0	-17,255
0 %	Sterling Investment Advisors, Ltd.	0	-34,928
0 %	Carson Wealth Management Group	0	-100,000
0 %	Morgan Stanley Smith Barney LLC	0	-29
0 %	Virtu Americas LLC	0	-75,240
0 %	Two Sigma Investments, LP	0	-25,238
0 %	Rockefeller Capital Management	0	-120
0 %	Morgan Stanley & Co. LLC	0	-1

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Premier A	공급업체고객	-0,05	-0,28	-0,15	0,05	-0,43	-0,36
HCA Healthcare	공급업체고객	-0,73	0,71	0,37	0,06	-0,51	-0,21

What values and corporate philosophy does Xtant Medical Holdings represent?

Xtant Medical Holdings Inc represents a commitment to improving patient lives through innovative medical solutions. With a focus on regenerative medicine products and services, Xtant Medical aims to empower surgeons and healthcare professionals to provide better outcomes for their patients. Emphasizing excellence, quality, and integrity, the company is dedicated to delivering state-of-the-art medical technologies that address complex spinal and orthopedic conditions. By leveraging cutting-edge research, clinical expertise, and advanced manufacturing capabilities, Xtant Medical strives to meet the evolving needs of patients, surgeons, and healthcare providers.

In which countries and regions is Xtant Medical Holdings primarily present?

Xtant Medical Holdings Inc is primarily present in the United States.

What significant milestones has the company Xtant Medical Holdings achieved?

Xtant Medical Holdings Inc has achieved significant milestones in its journey. The company has successfully expanded its product portfolio and established a strong presence in the medical industry. Xtant Medical Holdings Inc has consistently delivered innovative solutions and advanced technologies to provide better patient care. With its dedication to research and development, the company has introduced a range of groundbreaking products for spinal fusion and orthopedic surgeries. Xtant Medical Holdings Inc has also expanded its market reach by forming strategic partnerships and collaborations. These milestones demonstrate the company's commitment to advancing medical solutions and improving patient outcomes.

What is the history and background of the company Xtant Medical Holdings?

Xtant Medical Holdings Inc, a leading medical technology company, has a rich history and background. Founded in 2013, Xtant Medical specializes in the development, production, and commercialization of regenerative medicine products and implants that are used for orthopedic and neurological procedures. The company focuses on providing innovative solutions to enhance the healing and tissue regeneration process. Xtant Medical has an extensive product portfolio that includes bone grafts, spinal implants, and biologics. With a dedication to quality and patient outcomes, Xtant Medical has gained a strong presence in the industry, delivering advanced medical solutions to healthcare professionals and patients worldwide.

Who are the main competitors of Xtant Medical Holdings in the market?

The main competitors of Xtant Medical Holdings Inc in the market include Medtronic, Johnson & Johnson, Stryker Corporation, Zimmer Biomet Holdings Inc, and Globus Medical Inc.

In which industries is Xtant Medical Holdings primarily active?

Xtant Medical Holdings Inc is primarily active in the medical device and biotechnology industries.

What is the business model of Xtant Medical Holdings?

The business model of Xtant Medical Holdings Inc, a leading medical device company, focuses on developing, manufacturing, and commercializing innovative regenerative medicine products for orthopedic and neurological conditions. Xtant Medical Holdings Inc aims to enhance patient care and improve clinical outcomes through their extensive portfolio, which includes a range of biologics, implants, and instruments. By leveraging advanced technologies and strategic partnerships, Xtant Medical Holdings Inc strives to provide healthcare professionals with cutting-edge solutions to address the unmet needs of patients suffering from various musculoskeletal disorders and injuries. Please note that this answer has been optimized for SEO purposes, incorporating the company name, Xtant Medical Holdings Inc, throughout the response.

Xtant Medical Holdings 2024의 P/E 비율은 얼마입니까?

Xtant Medical Holdings의 P/E 비율은 -6.16입니다.

Xtant Medical Holdings 2024의 KUV는 얼마입니까?

Xtant Medical Holdings의 P/S 비율은 0.61입니다.

Xtant Medical Holdings의 AlleAktien 품질 점수는 얼마인가요?

Xtant Medical Holdings에 대한 AlleAktien 품질 점수는 5/10입니다.

Xtant Medical Holdings 2024의 매출은 얼마인가요?

예상되는 Xtant Medical Holdings 매출은 121.18 백만 USD입니다.

Xtant Medical Holdings 2024의 이익은 얼마인가요?

예상되는 Xtant Medical Holdings 이익은 -12.03 백만 USD입니다.

Xtant Medical Holdings은 무엇을 하나요?

Xtant Medical Holdings Inc. is a company specializing in the manufacture and distribution of orthopedic implants and biological products for the human body. The company is headquartered in Belgrade, Montana, USA and has branches in various regions, including Europe, Asia, and the Middle East. The business model of Xtant Medical is divided into two parts. Firstly, the company offers orthopedic implants such as knee, hip, and spinal supplements. Secondly, the company produces bone grafts and biological products that can promote bone growth. The company aims to produce a comprehensive range of high-quality medical implants and biological products that meet the diverse needs of patients worldwide. The implants and biological products are developed and manufactured by experienced surgeons and professionals to ensure the highest quality and safety. Xtant Medical also operates its own research and development department to continuously improve its products and develop new ones. A strong sales and marketing department is also present to acquire new customers and strengthen existing customer relationships. The company follows a multi-channel distribution strategy and works with distributors, sales partners, and direct sales teams. Some of Xtant Medical's main products include knee, hip, and spinal supplements. These implants are designed to improve the mobility and quality of life for patients. The implants are made of high-quality materials such as titanium, polyethylene, and ceramic and are available in different sizes to meet the individual needs of each patient. The company also produces a wide range of biological products that can promote bone growth. These products include bone grafts, synthetic bone substitutes, and growth factors. These products are used to repair and regenerate bones in various parts of the body. In addition to these products, Xtant Medical also offers various services, including training and education for surgeons, technical support, and customized solutions. Overall, Xtant Medical has a diversified business model that targets the needs of patients in different regions of the world. The company has a strong research and development department to continuously improve its products and operates a multi-channel distribution strategy to expand its customer base. With high-quality implants and biological products, as well as reliable customer service, Xtant Medical has established itself as one of the leading companies in the orthopedic industry.

Xtant Medical Holdings 배당금은 얼마입니까?

Xtant Medical Holdings은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Xtant Medical Holdings이 얼마나 자주 배당을 지급하나요?

Xtant Medical Holdings의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Xtant Medical Holdings ISIN이 무엇입니까?

Xtant Medical Holdings의 ISIN은 US98420P3082입니다.

Xtant Medical Holdings WKN은 무엇인가요?

Xtant Medical Holdings의 WKN은 A2JDJS입니다.

Xtant Medical Holdings 티커는 무엇인가요?

Xtant Medical Holdings의 티커는 XTNT입니다.

Xtant Medical Holdings이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Xtant Medical Holdings은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Xtant Medical Holdings은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Xtant Medical Holdings의 배당 수익률은 얼마입니까?

Xtant Medical Holdings의 현재 배당 수익률은 입니다.

Xtant Medical Holdings의 배당금은 언제 지급되나요?

Xtant Medical Holdings은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Xtant Medical Holdings의 배당금은 얼마나 안전한가요?

Xtant Medical Holdings은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Xtant Medical Holdings의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Xtant Medical Holdings이(가) 속해 있는 섹터는 어디인가요?

Xtant Medical Holdings은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Xtant Medical Holdings kaufen, um die vorherige Dividende zu erhalten?

Xtant Medical Holdings의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Xtant Medical Holdings의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Xtant Medical Holdings의 2023년도 배당금은 얼마였습니까?

2023년에 Xtant Medical Holdings는 0 USD를 배당금으로 지급했습니다.

Xtant Medical Holdings는 어떤 화폐로 배당금을 지급하나요?

Xtant Medical Holdings의 배당금은 USD에 지급됩니다.

증권거래소	Xtant Medical Holdings 티커
AMEX	XTNT
프랑크푸르트	XMS.F
뮌헨	XMS.MU

Xtant Medical Holdings 티커	Xtant Medical Holdings FIGI
XTNT:US	BBG000Q44D18
XTNT:UA	BBG000Q44D63
XTNT:UC	BBG000Q44DC6
XTNT:UN	BBG000Q44F59
XTNT:UP	BBG000Q44FF8
XTNT:UB	BBG000Q44GB0
XTNT:UT	BBG000Q44GL9
XTNT:UM	BBG000Q44GQ4
XTNT:UX	BBG000Q44H82
XTNT:UD	BBG000Q44JP9
XTNT:UF	BBG000Q44KZ5
XTNT:VY	BBG000Q44LB9
XTNT:VJ	BBG000Q44LG4
XTNT:VK	BBG000Q44LV7
XTNT:VF	BBG00DJGQPQ3
XTNTUSD:X2	BBG00JYT8197
XTNTUSD:XB	BBG00JYT81C3
XTNTUSD:XH	BBG00JYT81H8
XTNTUSD:XF	BBG00JYT81M2
XTNTUSD:XE	BBG00JYT81Q8
XTNTUSD:XJ	BBG00JYT81S6
XTNTUSD:XL	BBG00JYT81V2
XTNTUSD:XG	BBG00JYT81X0
XTNTUSD:XO	BBG00JYT81Z8
XTNTUSD:XS	BBG00JYT8231
XTNTUSD:XA	BBG00JYT8240
XTNTUSD:E1	BBG00JYT8259
XTNTUSD:XT	BBG00JYT8268
XTNTUSD:XW	BBG00JYT8277
XTNTUSD:XU	BBG00JYT8286
XTNTUSD:XV	BBG00JYT8295
XTNTUSD:XM	BBG00JYT82B2
XTNTUSD:XQ	BBG00JYT82D0
XTNTUSD:XX	BBG00JYT82F8
XTNTUSD:XZ	BBG00JYT82G7
XTNTUSD:EU	BBG00JYT82J4
XMS:GR	BBG00M90C141
XMS:GF	BBG00M90C150
XMS:GS	BBG00M90C187
XMS:GM	BBG00M90C196
XMS:GB	BBG00M90C1B3
XTNT:VG	BBG00X1P0NT8
XTNT:VP	BBG00X1SG480
XTNTUSD:EP	BBG00XRH4XG6
XTNTUSD:EZ	BBG00XRH4XL0
XMS:TH	BBG00ZHCNGM2
XTNTEUR:XS	BBG00ZS18KF0
XTNTEUR:XH	BBG00ZS18KJ6
XTNTEUR:XF	BBG00ZS18KL3
XTNTEUR:XE	BBG00ZS18KN1
XTNTEUR:XL	BBG00ZS18KQ8
XTNTEUR:XG	BBG00ZS18KR7
XTNTEUR:XO	BBG00ZS18KS6
XTNTEUR:XA	BBG00ZS18KX0
XTNTEUR:XT	BBG00ZS18KZ8
XTNTEUR:XW	BBG00ZS18L04
XTNTEUR:XU	BBG00ZS18L13
XTNTEUR:XV	BBG00ZS18L31
XTNTEUR:XM	BBG00ZS18L40
XTNTEUR:EU	BBG00ZS18LD0
XMS:LA	BBG018H9MW99
XMS:LU	BBG018J39F38
XMS:GZ	BBG01JYXK6C8

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

가격

가격

티커XTNT

ISINUS98420P3082

WKNA2JDJS

Xtant Medical Holdings 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Xtant Medical Holdings 주가 이력

Xtant Medical Holdings 주식 매출, EBIT, 이익 US98420P3082 · A2JDJS

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Xtant Medical Holdings 매출, 이익 및 EBIT 역사

Xtant Medical Holdings 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Xtant Medical Holdings 주식 마진 US98420P3082 · A2JDJS

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Xtant Medical Holdings 마진 역사

Xtant Medical Holdings 주식 매출, EBIT, 주당 순이익 US98420P3082 · A2JDJS

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Xtant Medical Holdings 매출, 이익 및 EBIT 주당 역사

Xtant Medical Holdings 주식 및 주식 분석

Xtant Medical Holdings 매출 세분화 US98420P3082 · A2JDJS

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Xtant Medical Holdings 매출 세분화

Xtant Medical Holdings 지역별 매출 US98420P3082 · A2JDJS

세그먼트별 매출

지역별 매출 개요

해석 및 사용법

투자 전략

Xtant Medical Holdings 매출 세분화

Xtant Medical Holdings Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Xtant Medical Holdings 역사적인 P/E, EBIT 및 P/S에 따른 평가

Xtant Medical Holdings 주식 수량 US98420P3082 · A2JDJS

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Xtant Medical Holdings 주식 분할

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

티커
XTNT

ISIN
US98420P3082

WKN
A2JDJS